2026-05-26 日報

🩺 醫藥健康每日摘要 - 第 108 期 (2026-05-26)

今日精選摘要報表

重點導讀

1. 數十年心臟病治療顛覆:數百萬人服用之常見心臟藥物被發現無效甚至可能危險(Common heart drug taken by millions found useless — and possibly dangerous)

分析段落:這項大規模國際研究顛覆了長達 40 年的心臟病發作治療方式,發現對於心臟功能正常的患者,常規處方的心臟病發作後乙型阻斷劑(beta-blockers)並無實質益處,甚至可能增加女性患者死亡或再發心臟病發作的風險。此發現將促使全球醫療指引進行重大調整,影響數百萬名病患的治療策略,對實證醫學和臨床實踐產生深遠影響。

2. 禮來公司基因編輯療法早期研究顯示能顯著降低膽固醇水平(Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study)

分析段落:禮來公司(Eli Lilly)宣佈,其基因編輯療法在早期臨床試驗中,能將受試者的膽固醇水平降低高達 62%。這項突破性成果預示著心血管疾病治療的新里程碑,未來可能提供一次性治療方案,有效管理甚至逆轉高膽固醇血症,對於預防動脈粥狀硬化和心臟病具有巨大潛力。

3. 科學家揭示 Ozempic 和 Wegovy 減重效果最終停滯的原因(Scientists discover why Ozempic and Wegovy weight loss eventually plateaus)

分析段落:美國國立衛生研究院(NIH)的新研究揭示了廣受歡迎的 GLP-1 類減重藥物(如 semaglutide)為何會出現減重平台期,並發現了延長其藥效的潛在途徑。這項發現深入理解了藥物對食慾控制腦細胞的影響,不僅有助於開發更有效的肥胖症治療策略,也為個人化用藥提供了新的方向。

4. 科學家成功強化自然殺手細胞以對抗侵襲性癌症(Scientists supercharge natural killer cells to fight aggressive cancers)

分析段落:麥吉爾大學(McGill University)的科學家發現了一種方法,透過暫時阻斷兩種蛋白質,來顯著增強免疫系統自然殺手(NK)細胞的抗癌能力。這項創新成果讓 NK 細胞能更有效地突破腫瘤防線,為白血病、膠質母細胞瘤、腎癌和三陰性乳癌等難治型癌症帶來了新的免疫療法希望。

5. 科學家發現肝臟內控制有害膽固醇的「隱藏開關」(Scientists discover hidden liver switch that cuts harmful cholesterol)

分析段落:西南醫學中心(UT Southwestern)的科學家發現了一個令人驚訝的「主開關」蛋白 HELZ2,它能關閉製造載脂蛋白 B(apoB)的基因指令。apoB 是導致動脈阻塞和心臟病的膽固醇攜帶粒子關鍵成分,這項發現為開發全新的、有別於現有藥物的降膽固醇療法提供了重要靶點。

6. 新型孕婦呼吸道融合病毒疫苗可降低嬰兒住院率,但可近性可能受限(New maternal RSV vaccine lowers infant hospitalization rates, but accessibility may be limited, study finds)

分析段落:呼吸道融合病毒(RSV)對嬰兒,尤其是六個月以下嬰兒,可能造成嚴重呼吸道併發症。這項研究指出新型孕婦 RSV 疫苗能有效降低嬰兒住院率,為公共衛生帶來顯著效益。然而,報告也強調其可近性可能存在限制,提醒政策制定者需關注疫苗公平分配問題,確保更多脆弱嬰兒獲得保護。

7. AI 導向藥物搜尋發現葉酸有助於糖尿病傷口癒合(AI-guided drug search flags folic acid for diabetic wound healing)

分析段落:新加坡國立大學研究人員開發了一套結合人工智慧與分子模擬的工作流程,成功識別出葉酸這種常見維生素,作為糖尿病傷口癒合的潛在藥物。這不僅展示了 AI 在加速藥物發現和舊藥新用方面的巨大潛力,也為糖尿病患者提供了可能更經濟、易得的治療選擇。


精細分類

Clinical (臨床研究與應用)

Guideline (醫療指引與政策)

Pharma (藥物研發與產業)

  • 歐洲慢性肝病:一場未被發現的可預防危機(Chronic liver disease in Europe: A preventable crisis going undetected)

    《柳葉刀區域健康—歐洲》系列文章指出,歐洲面臨日益嚴峻的慢性肝病威脅,強調必須將肝病視為超越肝臟專科的公共衛生問題,並將其更好地整合至歐洲醫療系統中。這項呼籲對於藥物研發,特別是針對脂肪肝和肝纖維化的新藥,提出了迫切需求。

AI Medicine (AI 醫療應用)

  • 【投書】政府千億「AI熱錢」,為何流不進本土應用新創?(【投書】政府千億「AI熱錢」,為何流不進本土應用新創?)

    這篇投書探討了台灣政府投入數千億資金發展 AI 產業,但這些「熱錢」卻難以流向本土 AI 應用和服務新創公司的現象。作者認為這與國發基金現行的「跟投」民間投資人模式有關,指出此模式可能不利於創新生態系的多元發展,值得政策制定者深思。

Public Health (公共衛生)

Nutrition & Lifestyle (營養與生活型態)

  • 甜菜汁在短短兩週內降低老年人血壓(Beet juice lowers blood pressure in older adults in just 2 weeks)

    一項大規模研究發現,老年人連續兩週每天飲用兩次濃縮甜菜汁,可顯著降低血壓。這項研究不僅支持了富含硝酸鹽的甜菜根對心臟健康的益處,還揭示了其可能透過改變口腔細菌群落來影響血壓,為自然降壓提供了新的生活型態介入策略。

  • 在貝魯特,難民女孩和婦女在武術課上學到的不僅是自衛(In Beirut, refugee girls and women learn more than self-defense in martial arts class)

    在黎巴嫩男性主導的巴勒斯坦難民營中,一位武術老師為婦女們提供了一條賦權之路。這項計畫超越了體能訓練,透過武術培養自信和力量,有助於改善難民婦女的心理健康和社會地位,是一種重要的生活型態和社會介入。

  • 伊莉莎白·史瑪特說:「我的身體承載了我。」現在她正在慶祝它。('My body carried me,' Elizabeth Smart says. Now she's celebrating it)

    被綁架經歷震驚國際的伊莉莎白·史瑪特分享她如何透過健身來克服身體羞恥感並重拾自信。她的故事強調了運動和身體建設不僅能改善體態,更能作為創傷復原和心理健康的強大工具,激勵人們以更積極的態度面對身體和生活。

  • 漫畫:要培養自信的小演說家,學習說「育兒語」(COMIC: To raise a confident little talker, learn to speak 'parentese')

    這篇漫畫解釋了與嬰兒對話的重要性,並分享了「育兒語」(parentese)如何幫助嬰兒發展語言技能。專家指出,用高音調、慢速和誇張語氣與寶寶交流,有助於他們的大腦處理語言信息,對兒童的早期發展和溝通能力培養有積極影響。

  • 轉動即贏:這家壽險公司如何將健康習慣變成一場遊戲(Spin to win: How this life insurance company turns healthy habits into a game)

    一家壽險公司正嘗試透過激勵機制,將健康習慣與降低保費和額外獎金掛鉤,以鼓勵客戶保持健康的生活型態,進而延長壽命。這種創新模式將健康管理遊戲化,有望促進大眾更積極地投入預防性健康行為。

  • 早點發現癌不「肺」力!中西醫談早期篩檢與養肺之道(早點發現癌不「肺」力!中西醫談早期篩檢與養肺之道)

    肺癌是台灣癌症死因前列的「沉默殺手」,早期症狀不明顯,常錯失治療黃金期。文章強調早期篩檢的重要性,並結合中西醫觀點,探討養肺之道。這對於提升公眾對肺癌篩檢的意識,推廣健康生活型態以預防疾病,具有重要的衛教意義。

  • 脂肪肝恐變成肝癌!4個脂肪肝常見迷思(脂肪肝恐變成肝癌!4個脂肪肝常見迷思)

    脂肪肝是現代人常見的健康問題,常因初期症狀不明而被忽視。文章澄清了關於脂肪肝的四個常見迷思,強調若長期不加控制,脂肪肝可能演變為肝炎、肝硬化甚至肝癌,並引發多種代謝疾病。這對於提升民眾對脂肪肝危害的認識,推廣健康飲食和生活型態以預防肝病至關重要。

其他未分類


English Daily Highlights

Today's medical and health news brings forth several pivotal developments, ranging from groundbreaking gene therapies and re-evaluations of long-standing drug protocols to advancements in cancer treatment and AI-driven drug discovery.

A major headline, potentially reshaping cardiovascular treatment paradigms, comes from a massive international study revealing that beta-blockers, routinely prescribed for 40 years post-uncomplicated heart attacks, offer no real benefit to patients with normal heart function. Shockingly, the study found that women taking these drugs faced a higher risk of adverse outcomes, including death or repeat heart attacks. This discovery is poised to necessitate significant updates in global clinical guidelines, impacting millions.

In the realm of innovative therapies, Eli Lilly announced promising early-phase data for Verve's gene-editing therapy (VERV-102), showing a remarkable 62% reduction in cholesterol levels in participants. This pioneering approach could revolutionize the treatment of hypercholesterolemia, potentially offering a one-time solution for a widespread chronic condition and marking a significant leap in gene therapy for cardiovascular health.

Understanding the mechanics of popular weight-loss drugs like Ozempic and Wegovy, new NIH research shed light on why their weight loss effects eventually plateau. The study identifies differential responses in appetite-controlling brain cells and suggests potential ways to extend the drugs' efficacy, which could lead to more personalized and effective obesity management strategies.

Cancer therapy sees a significant boost with McGill University scientists successfully "supercharging" natural killer (NK) cells. By temporarily blocking two specific proteins, they've enabled NK cells to overcome tumor defenses more effectively, offering new hope for aggressive cancers such as leukemia, glioblastoma, kidney cancer, and triple-negative breast cancer by turning these cells into far more effective fighters.

Further exciting discoveries in cardiovascular health include the identification of HELZ2, a "master switch" protein in the liver that controls the production of apoB, a key component of harmful cholesterol-carrying particles linked to clogged arteries. This finding by UT Southwestern scientists opens up an entirely new pathway for drug development, distinct from existing therapies, to combat high cholesterol and prevent heart disease.

Public health efforts against infectious diseases also received attention. A new study on maternal Respiratory Syncytial Virus (RSV) vaccine demonstrates its effectiveness in lowering infant hospitalization rates, a crucial development for protecting vulnerable newborns from severe respiratory complications. However, the study also highlights potential limitations in accessibility, emphasizing the need for equitable distribution.

Lastly, the growing influence of artificial intelligence in healthcare is evident, as researchers from the National University of Singapore leveraged AI and molecular simulations to identify folic acid, a common vitamin, as a promising candidate for diabetic wound healing. This showcases AI's potential to accelerate drug repurposing and provide accessible treatment options for complex conditions.

These developments underscore a dynamic landscape in medical research and public health, characterized by innovative therapeutic approaches, critical re-evaluation of established practices, and the increasing integration of advanced technologies like AI to address pressing global health challenges.